CXCL11 and hepatocellular carcinoma: After establishing a subcutaneous xenotransplanted tumor model of CAFs plus HCC cells in mice, we set out to validate the effects of LINC00152 knockdown and CXCL11 overexpression on tumor growth in vivo.